Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

Open Medicine Foundation Australia Ltd  (OMFAL) is a regional branch entity of Open Medicine Foundation, and is part of the largest, concerted worldwide nonprofit effort to diagnose, treat and find a cure for ME/CFS.

It was established for the purpose of promoting and funding research into multi-system chronic complex diseases, and supports the Melbourne ME/CFS Collaboration and a growing network of exceptional researchers in Australia.

Melbourne ME/CFS Collaboration

About the research center

Established in 2020, the Melbourne ME/CFS Collaboration is directed by Christopher W. Armstrong, PhD.

“We are tremendously grateful for the generous support from Emerge Australia, our Australian partner. Emerge Australia is a national organization providing information, support, and advocacy for people with ME/CFS — giving hope and help to more than 250,000 Australians living with the disease,”

Linda Tannenbaum, OMF Founder & CEO/President

The Melbourne ME/CFS Collaboration  seeks to characterize the unifying biological pathways of ME/CFS that relate to the shared disease experience between patients while also understanding each patient’s unique biology that creates variation in disease experience and severity.

Chris Armstrong, PhD, was OMF’s Science Liaison and a Visiting Scholar at Stanford. He completed his PhD in Biochemistry at the University of Melbourne, and has been involved with researching ME/CFS for over a decade. 

Dr. Armstrong is most well known for his research using metabolomics to observe biochemical alterations in ME/CFS patients. He began his work in this field at the University of Melbourne, beginning a PhD project to apply metabolomics to study  (ME/CFS) and published his first metabolomics study on blood and urine in 2015.

Since then Chris has set up collaborative efforts to apply metabolomics to immunological experiments on ME/CFS, observing how metabolism may relate to immune cell function. He has also focused on longitudinal research in ME/CFS while looking to extend metabolic capabilities across the field of ME/CFS to help collate different patient group

Core Aims

Develop

methods to understand the biology of the individual with ME/CFS.

Translate

understanding of the disease into practical treatment approaches.
 

Determine

the unifying biology between ME/CFS patients.

Understand

the development of ME/CFS in children and teenagers.

Reveal

the biology underlying ME/CFS symptoms.

Build

tools for research and treating ME/CFS.
biochemistry-biology-blue-2280571

Fundamental Philosophy

  • Every individual is biologically unique.
  • Disease biology is dynamic, not static.
  • Metabolism is strongly associated with symptom expression.
  • Define research questions and develop a research plan to answer them.
  • Measure the biology as it occurred in the body where possible.
  • Use extensive observations and data to generate hypotheses.
  • Translate research to tools that can be accessible to other researchers and clinicians.
  • Bring young scientists and clinicians into the research field.
  • Collaborate with experts out of our field and use their expertise.
  • Research biology at many layers, from biochemistry to cells to tissues

studies

General Practitioner Recruitment

General Practitioner Recruitment ME/CFS andLong COVID Myalgic Encephalomyeltis / Chronic Fatigue Syndrome (ME/CFS) is a multisystem, chronic and complex disease (msCCD) that, pre-COVID, affected around

Read More

Single Day Longitudinal Study

This project aims to test the nitrogen hypothesis, which is that damaging, nitrogen-containing by-products of energy metabolism accumulate more readily in the cells of ME/CFS patients.

Read More

Deep Proteome and Metabolome Profiling

Collaborate with OMF CRCs in Uppsala and Melbourne to establish a global perspective.

Decode the molecular mechanisms underlying ME/CFS and contributing to specific symptoms with a particular emphasis of post-exertional malaise (PEM) through:

Deep phenotyping of ME patients
Global proteomic plasma profiling of ME patients
Global metabolomics plasma profiling of ME patients

Read More

Developing Rapid System for Outlier Analysis in ME/CFS

Establish an analytical workflow for outlier analysis in ME/CFS to identify disease or symptom exacerbators that may not be considered in the individual with ME/CFS (including gene mutations, elevated toxins) and then develop a software program to rapidly identify these potential anomalies.

Read More

Scientific Team

To carry out these ambitious projects, Dr. Armstrong is establishing networks and collaborations extending to USA, UK, Sweden, and other Australian institutions. 

University of Melbourne, Australia

Paul Gooley, PhD

Natalie Thomas, PhD

Kathy Huang

Amber Jaa-Kwee

Xiaoyun Wang, PhD

Neil McGregor, PhD

David Ascher, PhD

Elisha Josev, PhD

Sarah Knight, PhD

Adam Scheinberg, MD

David Stroud, PhD

Rob Williams

Leigh Johnston, PhD

Stanford University, USA

Ronald Davis, PhD

Michael Snyder, PhD

Robert Phair, PhD

Laurel Crosby, PhD

Ryan Kellogg, PhD

Linda Lan, PhD

Julie Wilhelmy

Jaime Seltzer

Arshdeep Chauhan 

 

Uppsala University, Sweden

Jonas Bergquist, MD, PhD

Massachusetts General Hospital, USA

David Systrom, MD

Wenzhong Xiao, PhD

University of Montreal, Canada

Alain Moreau, PhD

Open Medicine Foundation

Linda Tannenbaum

UC San Diego, USA

Robert Naviaux, MD, PhD

University of Alabama Birmingham, USA

Jarred Younger, PhD

University College London, UK

Jo Cambridge, PhD

La Trobe University, Australia

Sarah Annesley, PhD

Paul Fisher, PhD

Daniel Missailidis

Australian National University, Australia

Brett Lidbury, PhD

Alice Richardson, PhD

Monash University, Australia

Joanne Fielding, PhD

Meaghan Clough, PhD

Did you know you can donate to OMF Australia with Crypto?

OMF Australia accepts donations of Cryptocurrencies

Make the most of your donation by donating your Bitcoin, Ethereum, and other cryptocurrencies directly to OMF Australia rather than selling and donating the after-tax proceeds.

  • Your tax deduction will be equal to the fair market value of the donated cryptocurrency (as determined by a qualified appraisal).
  • Donors should consult with a tax advisor for properly recording this donation on a personal tax return.

OMF Australia can accept cryptocurrency donations of any amount. 

Donating cryptocurrency is a non-taxable event, meaning you do not owe capital gains tax on the appreciated amount and can deduct it on your taxes. This makes Bitcoin and other cryptocurrency donations one of the most tax-efficient ways to support your favorite cause. If you want to learn more about how donating crypto can lower your taxes, check out thegivingblock.com/faq.

Talk to a crypto-savvy tax professional or connect with The Giving Block to get connected with one.

We accept the following cryptocurrencies: Bitcoin (BTC), Ether (ETH), Litecoin (LTC), Bitcoin Cash (BCH), Zcash (ZEC), Gemini Dollar (GUSD), Basic Attention Token (BAT), Chainlink (LINK), 0x (ZRX), Storj (STORJ), Dai (DAI), Amp (AMP), The Graph (GRT), UMA (UMA), 1inch (1INCH).

IRS Virtual Currencies FAQs